Announcements Trials
Browse Landscape

Status

Unknown 1Recruiting 1

Sponsor Class

OTHER 2NIH 1

Study Type

Observational 2

Sponsor

Cancer Type

Other hematologic neoplasm 4Thoracic 3Plasma cell 3Lymphoid 3CNS 3Myeloid 2Dermatologic 2Breast 2Other 1Gynecologic 1Genitourinary 1Classical hematology 1

Conditions

Breast Neoplasms 9481Triple Negative Breast Neoplasms 635Neoplasms 413Lung Neoplasms 342Prostatic Neoplasms 321Ovarian Neoplasms 299Colorectal Neoplasms 289Neoplasm Metastasis 280Motor Activity 267Carcinoma, Intraductal, Noninfiltrating 231Colonic Neoplasms 193Breast Neoplasms, Male 172Lymphedema 170Melanoma 158Pancreatic Neoplasms 152Breast Carcinoma In Situ 151Carcinoma, Non-Small-Cell Lung 149Uterine Cervical Neoplasms 144Fatigue 140Head and Neck Neoplasms 132Pain 122Breast Cancer Female 122Brain Neoplasms 118Stomach Neoplasms 117Sarcoma 106Depression 105Breast Cancer Lymphedema 101Anxiety Disorders 101Lymphoma 96Cardiotoxicity 89

Interventions

Mastectomy, Segmental 1Mammaplasty 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Autoimmune Diseases × Breast × Clear all
NCT02253251 2025-01-23

Clinical Validation of the Role of microRNA Binding Site Mutations in Cancer Risk, Prevention and Treatment

MiraKind

Recruiting
15,000 enrolled
BreastGynecologic

Autoimmune Diseases, Breast Neoplasms, Endometriosis, Neoplasms, Ovarian Neoplasms

NCT05400954 2023-04-28

AREOLA-B

The Netherlands Cancer Institute

Unknown
15,000 enrolled
Breast

Autoimmune Diseases, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡